- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 06.02. | Catheter Precision, Inc.: Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage | 3 | GlobeNewswire (USA) | ||
| 04.02. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.02. | Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC | 1 | GlobeNewswire (USA) | ||
| 17.01. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.01. | Catheter Precision, Inc: Catheter Precision to Attend the 30th International Atrial Fibrillation Symposium | 169 | ACCESS Newswire | FORT MILL, SOUTH CAROLINA / ACCESS Newswire / January 16, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products... ► Artikel lesen | |
| 15.01. | Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC | 156 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that... ► Artikel lesen | |
| 13.01. | Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center | 215 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / January 13, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it... ► Artikel lesen | |
| 07.01. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.01. | Catheter Precision names new CFO | 1 | Seeking Alpha | ||
| 07.01. | Catheter Precision, Inc. Announces New Chief Financial Officer | 175 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that... ► Artikel lesen | |
| 21.11.24 | Catheter Precision, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 14.11.24 | Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center | 314 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / November 14, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 13.11.24 | Ra Medical Systems reports Q3 results | 5 | Seeking Alpha | ||
| 13.11.24 | Catheter Precision, Inc. Announces Third Quarter Update and Financial Results | 190 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / November 13, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 04.11.24 | Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN | 232 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / November 4, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company, today announced that new clinical data from the VIVO EU... ► Artikel lesen | |
| 25.10.24 | Catheter Precision announces exercise of warrants for $4.9M of gross proceeds | 1 | Seeking Alpha | ||
| 25.10.24 | Catheter Precision, Inc. Announces Exercise of Warrants for $4.9 Million of Gross Proceeds | 411 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / October 25, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company, today announced the entry into a definitive agreement for... ► Artikel lesen | |
| 25.10.24 | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 23.10.24 | Catheter Precision, Inc: Catheter Precision to Attend Society for Cardiac Robotic Navigation With New Clinical Data Presented on October 28 - 29 | 179 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / October 23, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products announced that there... ► Artikel lesen | |
| 21.10.24 | Catheter Precision, Inc: Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO | 257 | ACCESS Newswire | FORT MILL, SC / ACCESSWIRE / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 61,55 | +0,24 % | Große Kursgewinne für den Anteilsschein von Eckert&Ziegler (61,15 €) | Zu den großen Gewinnern an der Börse zählt heute die Eckert&Ziegler-Aktie . Der Kurs der Aktie legt kräftig zu. Jahreschart der Eckert&Ziegler AG-Aktie, Stand 20.02.2025 Grund zur Freude haben Aktionäre... ► Artikel lesen | |
| DRAEGERWERK | 54,30 | -2,34 % | Kurs von Dräger fällt ab (55,10 €) | An der deutschen Börse liegt das Wertpapier von Dräger gegenwärtig im Minus. Zuletzt zahlten Investoren für das Wertpapier 55,10 Euro. Die Dräger-Aktie verzeichnet aktuell einen Kursverlust von 2,82... ► Artikel lesen | |
| BICO GROUP | 3,624 | +0,44 % | BICO Group AB: Publication of BICO Group AB: Year-end report 2024 | BICO Group AB 559050-5052 (NASDAQ STOCKHOLM: BICO)
Strengthened profitability in a challenging market environment and further reduced debt"We finished the year with strengthened profitability and operational... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,131 | -3,67 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,580 | -1,10 % | Geratherm Medical Aktie: Fortschritte führen zum Erfolg! | Die Geratherm Medical AG, ein Spezialist für medizinische Temperaturmesstechnik, verzeichnet einen vielversprechenden Jahresbeginn 2025. Der Aktienkurs des Unternehmens stieg am 17. Januar auf 3,68... ► Artikel lesen | |
| CARDINAL HEALTH | 120,95 | -0,29 % | Elliott Investment Management exits Cardinal Health, cuts NRG Energy, Southwest Air | ||
| RESMED | 220,90 | -1,03 % | RESMED INC: Update - Dividend/Distribution - RMD | ||
| ATOSSA THERAPEUTICS | 0,790 | -7,49 % | Atossa Therapeutics, Inc. (NASDAQ:ATOS) Sees Significant Growth in Short Interest | ||
| HENRY SCHEIN | 74,56 | +0,30 % | Henry Schein Aktie: Was die Analysten sagen | Die Henry Schein Aktie verzeichnet derzeit eine verhaltene Marktentwicklung und notierte am 15. Februar bei 72,42 EUR, was einem leichten Rückgang von 0,06 Prozent entspricht. Der Gesundheitsprodukte-Spezialist... ► Artikel lesen | |
| UNIDOC HEALTH | 0,296 | -0,67 % | Zocker, aufgepasst: InnoCan, Xorx Therapeutics, Unidoc Health | Börsenzockern, die sich derzeit an Aktien wie InnoCan, Xorx Therapeutics oder Unidoc Health versuchen, sei gesagt: Berichterstattungen zu hochspekulativen Werten dieser Art unterliegen oft massiven... ► Artikel lesen | |
| ZIMMER BIOMET | 98,36 | -0,32 % | Laufende Fusionskontrollverfahren: Zimmer Biomet Holdings, Inc., Warsaw, Indiana (USA); mittelbarer Erwerb über sämtliche Anteile an der und Kontrolle über die Paragon 28, Inc., Englewood, Colorado (USA) | Datum der Anmeldung:12.02.2025Aktenzeichen:B3-31/25Unternehmen:Zimmer Biomet Holdings, Inc., Warsaw, Indiana (USA); mittelbarer Erwerb über sämtliche Anteile an der und Kontrolle über die Paragon 28... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results | Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,675 | -0,74 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 1,158 | +7,02 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
| VERU | 0,562 | -1,40 % | Veru Inc. Direktor Michael Rankowitz erwirbt Stammaktien im Wert von 84.350 US-Dollar |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,355 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.
